PubMed=1770930
Murakami T., Nakamura M., Kusanagi H., Suzuki T.
Establishment and characterization of human esophageal carcinoma cell lines -- especially the role of the serum-free culture.
Nihon Geka Gakkai Zasshi 92:1563-1570(1991)

PubMed=1819237
Nakamura M.
Establishment and characterization of a new human esophageal cancer cell line (YES-1).
Nihon Geka Hokan 60:3-12(1991)

DOI=10.5833/jjgs.27.1885
Kusanagi H.
Effect of epidermal growth factor (EGF) on human esophageal cancer cell lines in a protein-free medium and the expression of EGF receptors on the cells.
Nihon Shokaki Geka Gakkai Zasshi 27:1885-1891(1994)

PubMed=8590302; DOI=10.1089/jir.1995.15.1005
Oka M., Hirose K., Iizuka N., Aoyagi K., Yamamoto K., Abe T., Hazama S., Suzuki T.
Cytokine mRNA expression patterns in human esophageal cancer cell lines.
J. Interferon Cytokine Res. 15:1005-1009(1995)

PubMed=8974001; DOI=10.1089/jir.1996.16.1001
Oka M., Iizuka N., Yamamoto K., Gondo T., Abe T., Hazama S., Akitomi Y., Koishihara Y., Ohsugi Y., Ooba Y., Ishihara T., Suzuki T.
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
J. Interferon Cytokine Res. 16:1001-1006(1996)

PubMed=11115554; DOI=10.3892/ijo.18.1.157
Fujii T., Kato S., Yamana H., Tanaka Y., Fujita H., Shirouzu K., Morimatsu M.
Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus.
Int. J. Oncol. 18:157-163(2001)

PubMed=18575732; DOI=10.3892/or.20.1.155
Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S.
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20:155-163(2008)

PubMed=18973137; DOI=10.1002/gcc.20626
Sugimoto T., Seki N., Shimizu S., Kikkawa N., Tsukada J., Shimada H., Sasaki K., Hanazawa T., Okamoto Y., Hata A.
The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma.
Genes Chromosomes Cancer 48:132-142(2009)

PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061
Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y., Kusukawa J., Kage M., Shirouzu K., Yamana H.
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Mol. Cancer Ther. 9:1842-1851(2010)